Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?

Schluger N. W.

Source: Eur Respir J 2007; 30: 825-827

Journal Issue: November

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Schluger N. W.. Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?. Eur Respir J 2007; 30: 825-827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Clean air in Europe: beyond the horizon? Source: Eur Respir J 2015; 45: 7-10 Year: 2015
The air of Europe: where are we going? Source: Eur Respir Rev, 26 (146) 170024; 10.1183/16000617.0024-2017 Year: 2017
Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis Year: 2010
Tuberculosis situation and control in Europe: where are we and what to do next? Source: Eur Respir J 2005; 26: Suppl. 49, 476s Year: 2005
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania Source: Annual Congress 2007 - Tuberculosis control Year: 2007
Dynamics of MBT drug resistance in Saratov Region Hospital, Russia Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Tuberculosis in Germany: a declining trend coming to an end? Source: Eur Respir J 2016; 47: 667-670 Year: 2016
Seasonality of tuberculosis in an Eastern-Asian country with an extreme continental climate Source: Eur Respir J 2009; 34: 921-925 Year: 2009
Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016
Impact of African immigration on drug resistance to mycobacterium tuberculosis in Portugal Source: Annual Congress 2011 - Tuberculosis in special populations Year: 2011
Tuberculosis elimination in Oman: winning the war on the disease Source: ERJ Open Res, 4 (4) 00121-2018; 10.1183/23120541.00121-2018 Year: 2018
TB elimination: a dream or a reality? Key lessons from the ERS external course in Dubrovnik, Croatia Source: Breathe 2013; 9: 458-461 Year: 2013
XDR-TB in South Africa: from clinical management to public-health action Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013 Source: International Congress 2015 – Management of TB: a patient focus Year: 2015